
European CDMO network specializing in peptide API manufacturing across multiple facilities. Frankfurt site offers early clinical peptide APIs and R&D. Muttenz site developing new GLP-1 plant as part of 900M EUR investment.
Claim this listing to update your information, respond to buyer inquiries, and get a verified badge.
Free to claim. Verified upgrades available.